GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (OTCPK:PHGUF) » Definitions » Cash Flow for Dividends

PHGUF (Pharming Group) Cash Flow for Dividends : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Pharming Group Cash Flow for Dividends?

Pharming Group's cash flow for dividends for the three months ended in Dec. 2024 was $0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.


Pharming Group Cash Flow for Dividends Historical Data

The historical data trend for Pharming Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Cash Flow for Dividends Chart

Pharming Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pharming Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharming Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharming Group Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Pharming Group's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group Business Description

Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group Headlines

From GuruFocus

Q3 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q4 2021 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q1 2021 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q3 2024 Pharming Group NV Earnings Call Transcript

By GuruFocus News 10-25-2024

Q4 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 03-15-2024

Q2 2021 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q4 2024 Pharming Group NV Earnings Call Transcript

By GuruFocus News 03-14-2025

Q2 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q1 2022 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024